Daily Roundup

MCE.ASX FID.ASX CAT.ASX AIH.ASX BOT.ASX

A Flurry of Deals and Settlements in the Australian Markets

Advanced Innergy Holdings (AIH) has set its sights on a major acquisition, submitting a non-binding proposal to buy out Matrix Composites & Engineering (MCE) for $0.40 per share. This offer represents a juicy 66.7% premium over MCE's closing price on March 26th. AIH believes the combination will help it build a market-leading platform in technical buoyancy and subsea equipment, strengthening its presence in the Asia-Pacific region.

Meanwhile, Fiducian Group has reached a settlement with the Australian Securities and Investments Commission (ASIC) over civil proceedings. Its subsidiary, Fiducian Investment Management Services (FIMS), will pay a $7.3 million penalty and ASIC's $650,000 in legal costs. The court will also make declarations regarding FIMS' conduct related to misleading statements in product disclosure documents.

Over at Catapult Sports, the company hosted its FY26 Analyst Day, highlighting the importance of growing its average contract value (ACV) per pro team to achieve its ambitious goals. However, the financial information shared was for illustrative purposes only and does not constitute guidance or a forecast.

In other news, Botanix Pharmaceuticals has successfully renegotiated its active pharmaceutical ingredient (API) supply agreement with Kaken Pharmaceutical. The key changes include deferring upcoming API purchases to December 2027 and December 2028, allowing Botanix to strengthen its financial position and pursue growth plans for its Sofdra product.

It's been a busy day in the Australian markets, with major deals, settlements, and strategic updates keeping investors on their toes. As always, it's crucial to do your own research and consult with a financial advisor before making any investment decisions.